Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Asset Writedowns and Impairment (2023 - 2025)

Vsee Health (VSEE) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with $274215.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Writedowns and Impairment fell 14.63% year-over-year to $274215.0, compared with a TTM value of $692746.0 through Sep 2025, up 148.05%, and an annual FY2024 reading of $514282.0, up 1484.5% over the prior year.
  • Asset Writedowns and Impairment was $274215.0 for Q3 2025 at Vsee Health, up from $125964.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $321206.0 in Q3 2024 and bottomed at -$63358.0 in Q4 2023.
  • Average Asset Writedowns and Impairment over 3 years is $108492.4, with a median of $120919.0 recorded in 2025.
  • Peak annual rise in Asset Writedowns and Impairment hit 1214.19% in 2025, while the deepest fall reached 14.63% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at -$63358.0 in 2023, then soared by 370.92% to $171648.0 in 2024, then soared by 59.75% to $274215.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for VSEE at $274215.0 in Q3 2025, $125964.0 in Q2 2025, and $120919.0 in Q1 2025.